Michael Weaver, MD

Fact Sheet

Teaching Relapse Prevention Techniques in Alcohol Use Disorder

January 1, 2025

Michael Weaver, MD, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Weaver, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Most patients are not able to achieve sobriety from opioids in their first attempt.

Detox: An Overview

September 1, 2017

Michael Weaver, MD

Michael Weaver, MD Professor and medical director at the Center for Neurobehavioral Research on Addiction at the University of Texas Medical School. Author of Addiction Treatment (Carlat Publishing, 2017). Dr. Weaver has disclosed that he received payment from Indivior in the past 12 months. Dr. Carlat has reviewed this article and has found no evidence of bias in this educational activity.

Detox (also known as “medically supervised withdrawal”) refers to treatment to help patients withdraw from substances that cause physical dependence, such as alcohol, sedative-hypnotics, and opioids. But detox is far more than a several-day process of ridding the body of an addictive substance. It should be considered an important component in the overall care and treatment of addiction.

Recognizing and Reversing Relapse

May 1, 2017

Michael Weaver, MD

Michael Weaver, MD Medical director, Center for Neurobehavioral Research on Addiction Dr. Weaver has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Addiction treatment often begins with high hopes and apparent success, but it’s important to remember that addiction is a disease with a relapse rate of 40%–60%. Be realistic: Expect that patients will go through cycles of relapse and recovery. Learn the warning signs for relapse, the measures you can take to prevent it, and what to do after it has occurred.

Treating Alcohol Use Disorder—A Fact Book (2023)

PDF/eBook and CME Access

February 28, 2017

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Alcohol Use Disorder—A Fact Book (2023). All versions of this product include access to the 6 CME Post-Test.

Treating Alcohol Use Disorder—A Fact Book (2023)

Print Copy with PDF/eBook and CME Access

February 28, 2017

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP

Daniel Carlat, MD, Michael Weaver, MD, and Talia Puzantian, PharmD, BCPP, have no financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Treating Alcohol Use Disorder—A Fact Book (2023). All versions of this product include access to the 6 CME Post-Test.

Addiction Treatment—A Carlat Guide (2017)

PDF/eBook and CME Access

February 28, 2017

Michael Weaver, MD

Michael Weaver, MD Medical director, Center for Neurobehavioral Research on Addiction Dr. Weaver has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This page has links and instructions for downloading your PDF and eBook copies of Addiction Treatment--A Carlat Guide. All versions of this product include access to the 8 CME Post-Test.

Addiction Treatment–A Carlat Guide (2017)

PDF Access and CME Post-Test

February 28, 2017

Michael Weaver, MD

This page has links and instructions for downloading your PDF and eBook copies of Addiction Treatment–A Carlat Guide and gives you access to the 8 CME post-test.